> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Receives Request for Exemption for Glucose Test System
- URL: https://www.fdaweb.com/fda-receives-request-for-exemption-for-glucose-test-system/
- Published: 2016-03-24T12:00:00.000Z
- Updated: 2026-09-14T20:50:56.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5135181

*Federal Register* Notice: FDA is announcing that it has received a petition requesting exemption from the premarket notification requirements for a method, metallic reduction, glucose (urinary, non-quantitative) test system in a reagent tablet format that is intended to measure glucosuria (glucose in urine). These test systems in a are used in diagnosing and treating carbohydrate metabolism disorders including diabetes mellitus, hypoglycemia, and hyperglycemia. To view this notice, click [here.](https://www.gpo.gov/fdsys/pkg/FR-2016-03-24/pdf/2016-06709.pdf?ref=fdaweb.com)